CCXI - ChemoCentryx: Good Post-Approval Performance But Needs More Time March, 03 2022 02:06 PM ChemoCentryx Inc. CCXI got its first approval last October. Revenue and patient uptake has been good. A few more quarters will be needed to assess the company properly. For further details see: ChemoCentryx: Good Post-Approval Performance, But Needs More Time